Polymorphisms of extrinsic death receptor apoptotic genes (FAS −670 G>A, FASL −844 T>C) in coronary artery disease

被引:0
作者
G. Kishore Kumar
G. Rajesh Kumar
K. Mrudula Spurthi
S. Nivas
P. Chiranjeevi
Altaf Ali
S. K. Sahu
N. Pratibha
H. Surekha Rani
机构
[1] Osmania University,Department of Genetics
[2] Durgabai Deshmukh Hospital and Research Center,undefined
来源
Apoptosis | 2016年 / 21卷
关键词
CAD; Apoptosis; FAS; FASL; Plaque rupture;
D O I
暂无
中图分类号
学科分类号
摘要
Apoptosis plays an important role in atherogenesis and rupture of vulnerable plaques in coronary artery disease. FAS and FAS ligand (FASL) induce apoptosis when FAS binds to FAS-L. However sFas blocks apoptosis by binding to FAS and FASL or sFasL. The present study is sought to examine the role of extrinsic apoptotic genes (FAS, FASL) polymorphism and serum levels of FAS, FASL in the pathogenesis and susceptibility to CAD in south Indian population. The study included 300 CAD patients and 300 healthy controls. Lipid profiles, sFas, sFasL were estimated by commercially available kits. FAS −670 G>A, FASL −844 T>C genotypes were analyzed by PCR–RFLP. Secondary structures of pre mRNA were analyzed by the Vienna RNA webserver and gene–gene and gene–environment interactions were determined by MDR analysis. Total cholesterol, triglyceride and LDL levels were significantly high in CAD patients compared to the controls. Molecular analysis revealed that the frequency of the AA genotype of FAS (54 % vs 27 %) and CC genotypes of FASL (10.3 % vs 1.3 %) were high in CAD patients compared to controls. Secondary structure analysis of FAS and FASL confirmed our molecular analysis. sFas levels were low while serum sFasL were high in CAD patients. MDR analysis revealed synergistic effects of gene polymorphisms and additive effects of epidemiological factors on risk of CAD. Polymorphisms of FAS (−670 G/A), FASL (−844 T/C) and their circulating levels play an important role in the pathology of CAD.
引用
收藏
页码:558 / 565
页数:7
相关论文
共 138 条
[31]  
Koutang C(2007)Increased soluble FAS plasma levels in subjects at high cardiovascular risk atorvastatin on inflammatory markers (AIM) study, a substudy of ACTFAST Arterioscler Thromb Vasc Biol 27 168-undefined
[32]  
Lohse P(2011)A polymorphic −844T/C in FASL promoter predicts survival and relapse in non-small cell lung cancer Clin Cancer Res 17 5991-undefined
[33]  
Reichart B(2003)A novel polymorphic CAAT/enhancer-binding protein β element in the FASL gene promoter alters FAS ligand expression: a candidate background gene in African American systemic lupus erythematosus patients J Immunol 170 132-undefined
[34]  
Lohse P(2012)The relationship of serum soluble FAS ligand (sFasL) level with the extent of coronary artery disease Int J Angiol 21 29-undefined
[35]  
Shimeru K(undefined)undefined undefined undefined undefined-undefined
[36]  
Yasuaki Y(undefined)undefined undefined undefined undefined-undefined
[37]  
Samaneh BN(undefined)undefined undefined undefined undefined-undefined
[38]  
Hamid RS(undefined)undefined undefined undefined undefined-undefined
[39]  
Kamran G(undefined)undefined undefined undefined undefined-undefined
[40]  
Mostafa J(undefined)undefined undefined undefined undefined-undefined